1. Home
  2. KYTX vs RDCM Comparison

KYTX vs RDCM Comparison

Compare KYTX & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • RDCM
  • Stock Information
  • Founded
  • KYTX 2018
  • RDCM 1985
  • Country
  • KYTX United States
  • RDCM Israel
  • Employees
  • KYTX N/A
  • RDCM N/A
  • Industry
  • KYTX
  • RDCM Computer peripheral equipment
  • Sector
  • KYTX
  • RDCM Technology
  • Exchange
  • KYTX NYSE
  • RDCM Nasdaq
  • Market Cap
  • KYTX 196.4M
  • RDCM 157.9M
  • IPO Year
  • KYTX 2024
  • RDCM 1997
  • Fundamental
  • Price
  • KYTX $3.98
  • RDCM $11.73
  • Analyst Decision
  • KYTX Buy
  • RDCM Strong Buy
  • Analyst Count
  • KYTX 5
  • RDCM 1
  • Target Price
  • KYTX $23.20
  • RDCM $14.00
  • AVG Volume (30 Days)
  • KYTX 453.0K
  • RDCM 67.9K
  • Earning Date
  • KYTX 02-12-2025
  • RDCM 01-29-2025
  • Dividend Yield
  • KYTX N/A
  • RDCM N/A
  • EPS Growth
  • KYTX N/A
  • RDCM 660.55
  • EPS
  • KYTX N/A
  • RDCM 0.46
  • Revenue
  • KYTX N/A
  • RDCM $58,755,000.00
  • Revenue This Year
  • KYTX N/A
  • RDCM $18.92
  • Revenue Next Year
  • KYTX N/A
  • RDCM $11.27
  • P/E Ratio
  • KYTX N/A
  • RDCM $25.60
  • Revenue Growth
  • KYTX N/A
  • RDCM 17.80
  • 52 Week Low
  • KYTX $3.63
  • RDCM $7.70
  • 52 Week High
  • KYTX $30.60
  • RDCM $12.84
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 38.40
  • RDCM 49.07
  • Support Level
  • KYTX $3.63
  • RDCM $11.46
  • Resistance Level
  • KYTX $4.60
  • RDCM $12.32
  • Average True Range (ATR)
  • KYTX 0.45
  • RDCM 0.56
  • MACD
  • KYTX -0.10
  • RDCM -0.10
  • Stochastic Oscillator
  • KYTX 8.58
  • RDCM 9.63

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

Share on Social Networks: